This review will summarize the development of insulin analogs, discuss the results of insulin trials in people with MDI-treated type 1 diabetes at increased risk of hypoglycemia, and compare these results with studies in people at low risk of hypoglycemia. This evidence concerns the gene INS and type 1 diabetes mellitus.